Yabao Pharmaceutical Group Co (SHSE:600351) COGS-to-Revenue : 0.47 (As of Mar. 2025)

View and export this data going back to 2002. Start your Free Trial

What is Yabao Pharmaceutical Group Co COGS-to-Revenue?

Yabao Pharmaceutical Group Co's Cost of Goods Sold for the three months ended in Mar. 2025 was ¥289 Mil. Its Revenue for the three months ended in Mar. 2025 was ¥615 Mil.

Yabao Pharmaceutical Group Co's COGS to Revenue for the three months ended in Mar. 2025 was 0.47.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Yabao Pharmaceutical Group Co's Gross Margin % for the three months ended in Mar. 2025 was 52.93%.

Yabao Pharmaceutical Group Co COGS-to-Revenue Historical Data

The historical data trend for Yabao Pharmaceutical Group Co's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Yabao Pharmaceutical Group Co COGS-to-Revenue Chart

Yabao Pharmaceutical Group Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

COGS-to-Revenue

Get a 7-Day Free Trial

0.41

0.39

0.44

0.42

0.48

Yabao Pharmaceutical Group Co Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
COGS-to-Revenue	Get a 7-Day Free Trial															0.44	0.48	0.54	0.49	0.47

Yabao Pharmaceutical Group Co COGS-to-Revenue Calculation

Yabao Pharmaceutical Group Co's COGS to Revenue for the fiscal year that ended in Dec. 2024 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	1297.854	/	2686.038
	=	0.48

Yabao Pharmaceutical Group Co's COGS to Revenue for the quarter that ended in Mar. 2025 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	289.256	/	614.533
	=	0.47

Yabao Pharmaceutical Group Co (SHSE:600351) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Yabao Pharmaceutical Group Co's Gross Margin % for the three months ended in Mar. 2025 is calculated as:

Gross Margin %	=	1	-	COGS to Revenue
	=	1	-	Cost of Goods Sold / Revenue
	=	1	-	289.256 / 614.533
	=	52.93 %

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

Yabao Pharmaceutical Group Co COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Yabao Pharmaceutical Group Co's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Yabao Pharmaceutical Group Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Yabao Pharmaceutical Group Co Ltd (SHSE:600351) » Definitions » COGS-to-Revenue

Traded in Other Exchanges

N/A

Address

No.43 Fumin Road, Ruicheng, Shanxi Province, Yuncheng, CHN, 044602

Website

http://www.yabao.com.cn

Yabao Pharmaceutical Group Co Ltd is engaged in the manufacture and operation of western and Chinese medicines, APIs, health care products, packing materials for medicine, and also engages in the planting and processing of medicinal herbs.

Executives

Tang Ke	senior management
Zuo Zhe Feng	senior management
Xu Zhen Jiang	Supervisors
Wang Gang	senior management
Ren Peng Bo	Director
Ren Wei	senior management
Ning Hui Qiang	Supervisors
Ren Wu Xian	Director

Yabao Pharmaceutical Group Co Headlines

No Headlines